| Arsenic trioxide | Trisenox® (Cephalon® Oncology) | For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) transloc | Drug Information Portal
MedlinePlus |
| Tretinoin | Vesanoid® (Roche Pharmaceuticals) | Induction of remission in patients with acute promyelocytic leukemia who are refractory to or unable to tolerate anthracycline based cytotoxic chemotherapeutic regimens. | Drug Information Portal
MedlinePlus |